Log in

CVE:IFXImaflex Stock Price, Forecast & News

C$0.65
-0.03 (-4.41 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.65
Now: C$0.65
C$0.68
50-Day Range
C$0.51
MA: C$0.65
C$0.76
52-Week Range
C$0.36
Now: C$0.65
C$0.76
Volume3,000 shs
Average Volume19,444 shs
Market CapitalizationC$32.51 million
P/E Ratio8.13
Dividend YieldN/A
BetaN/A
Imaflex Inc., together with its subsidiary, develops, manufactures, and sells flexible packaging materials for consumer, industrial, and agriculture markets in Canada, the United States, and internationally. The company offers agricultural films, including mulch and barrier, compostable, UV-reflective, and intelligent active ingredient films; converter films; industrial products, such as garbage, compostable, and Gaylord bags, as well as bags on roll products; and metalized pest repellency films. It primarily operates under the ADVASEAL name. The company was founded in 1994 and is headquartered in Montreal, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.90 out of 5 stars


Industry, Sector and Symbol

Industry Packaging & Containers
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+1-514-9355710

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$80.23 million
Cash FlowC$0.00 per share
Book ValueC$0.66 per share

Profitability

Miscellaneous

Employees252
Market CapC$32.51 million
Next Earnings Date8/25/2020 (Estimated)
OptionableNot Optionable

Receive IFX News and Ratings via Email

Sign-up to receive the latest news and ratings for IFX and its competitors with MarketBeat's FREE daily newsletter.

Imaflex (CVE:IFX) Frequently Asked Questions

How has Imaflex's stock been impacted by COVID-19 (Coronavirus)?

Imaflex's stock was trading at C$0.55 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IFX stock has increased by 18.2% and is now trading at C$0.65. View which stocks have been most impacted by Coronavirus.

When is Imaflex's next earnings date?

Imaflex is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Imaflex.

How were Imaflex's earnings last quarter?

Imaflex Inc. (CVE:IFX) issued its quarterly earnings results on Wednesday, May, 27th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.05. The company earned $21.03 million during the quarter, compared to analysts' expectations of $21.90 million. View Imaflex's earnings history.

Has Imaflex been receiving favorable news coverage?

News articles about IFX stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Imaflex earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future. View the latest news about Imaflex.

Who are some of Imaflex's key competitors?

What other stocks do shareholders of Imaflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imaflex investors own include Walt Disney (DIS), KeyCorp (KEY), Greenbrier Companies (GBX), 1ST TR LARGE CA/COM (FTA), Drive Shack (DS), DryShips (DRYS), Docusign (DOCU), iShares 1-3 Year Credit Bond ETF (CSJ), Global Cord Blood (CO) and Cboe Global Markets (CBOE).

Who are Imaflex's key executives?

Imaflex's management team includes the following people:
  • Mr. Joseph Marino Abbandonato, Chairman, Pres & CEO
  • Mr. Giancarlo Santella CPA, CA, Chief Financial Officer
  • Mr. Philip Patrick Joseph Nolan LLB, Legal Counsel & Director (Age 57)
  • Mr. John Ripplinger, Vice-Pres of Corp. Affairs
  • Dr. Ralf Dujardin, VP of Marketing & Innovation

What is Imaflex's stock symbol?

Imaflex trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IFX."

How do I buy shares of Imaflex?

Shares of IFX and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Imaflex's stock price today?

One share of IFX stock can currently be purchased for approximately C$0.65.

How big of a company is Imaflex?

Imaflex has a market capitalization of C$32.51 million and generates C$80.23 million in revenue each year. Imaflex employs 252 workers across the globe.

What is Imaflex's official website?

The official website for Imaflex is www.imaflex.com.

How can I contact Imaflex?

Imaflex's mailing address is 5710 Notre-Dame St W, MONTREAL, QC H4C 1V2, Canada. The company can be reached via phone at +1-514-9355710.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.